Latin America Hypodermic Syringes And Needles Market Size, Share & Trends Analysis Report By Type (Needles, Syringes, Combination), By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The Latin America hypodermic syringes and needles market was valued at USD 196.07 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.7% from 2023 to 2030. The increasing prevalence of chronic disorders, rising number of surgeries, and increasing demand for syringes for mass vaccination are the primary factors driving the demand for hypodermic syringes and needles.  

The COVID-19 pandemic had a significantly positive impact on the hypodermic syringes and needles market. The pandemic drastically increased the demand for medicines, medical disposable products, emergency supplies, and hospital equipment. Hypodermic needles are used in blood sampling. Patients suffering from COVID-19 experiences various challenges and changes that may have elevated the demand for blood sampling. Therefore, the sudden rise in the demand for blood sampling resulted in a substantial increase in sales of hypodermic syringes & needles during the pandemic.

Moreover, the development of COVID-19 vaccines became the top priority to limit the spread of the infection. Most vaccinations, including those currently approved for COVID-19, are administered subcutaneously and intramuscularly using hypodermic needles. Hypodermic syringes and needles are readily available & cheaper, which makes them immediately attractive for delivering vaccines to a large cohort of patients. This made hypodermic needles an ideal choice for delivering COVID-19 vaccines. Thus, the COVID-19 pandemic had a significantly positive impact on the sales of hypodermic syringes and needles.  

In addition, with the world moving towards normalcy and increasing funds being allocated towards healthcare, significant advancements are being carried out. These advancements are expected to increase the number of individuals opting for medical procedures leading to a rise in sales of the hypodermic syringes and needles market over the forecast period.  

Hypodermic needles are generally used by healthcare professionals. However, patients sometimes use these needles themselves. The usage is most common among diabetic patients who require several insulin shots per day and among patients with asthma or severe allergies. Thus, a rise in the prevalence of diabetes, asthma, and other serious allergies is expected to propel market growth.

Diabetes presents a major health crisis in Latin American countries and is one of the leading causes of death from a chronic non-communicable disease. There is a disproportionate surge of diabetes in Latin America in comparison with other Western countries. It can be due to the genetic, socioeconomic, and environmental predisposition of this regional population for various risk factors of type 2 diabetes mellitus (T2DM), such as insulin resistance, obesity, & other metabolic disorders.

According to the International Diabetes Federation’s 2021 statistics, people with diabetes in the South and Central America region will increase by 48% and is expected to reach 49 million by 2045. This is indicative of the increase in the prevalence of diabetes by 25%, reaching 11.9% by 2045. In 2021, USD 65.3 billion was spent on diabetes in the South and Central America region, which represents 6.7% of the total spent worldwide.

Type Insights

The syringes segment dominated the market with the highest revenue share in 2022 owing to the rise in the number of surgeries and increasing adoption of syringes in these procedures. In addition, the growing prevalence of chronic diseases such as diabetes is also driving the demand for the hypodermic syringes and needles market.

Moreover, increasing product launches by key players to meet the growing demand and expand their product portfolio is also leading toward segment growth. For instance, in September 2022, BD introduced a next-generation glass Prefillable Syringe (PFS), which offers new and stronger criteria for processability, cosmetics, contamination, and integrity.

On the other hand, the needles segment is anticipated to experience maximum growth over the forecast period with the highest CAGR. Factors such as increasing usage of these needles to deliver drugs, and vaccines as well as to collect blood specimen is expected to lead to a surge in sales of it. This is expected to fuel the growth of the segment in the near future.

Country Insights

Brazil dominated the Latin America hypodermic syringes and needles market with the highest revenue share in 2022. An increase in the number of hospitals and a rise in the prevalence of various diseases, such as COVID-19, TB, Zika virus, malaria, & typhoid, are factors leading to growth in the number of patients being hospitalized, which is anticipated to drive the demand for hypodermic needles & syringes. These diseases require blood sampling and pathogenic testing for further treatment.

In addition, the COVID-19 outbreak has significantly increased the demand for hypodermic syringes and needles due to the growing number of hospital admissions in Brazil. For instance, according to a report published by WHO in September 2022, more than 34,644,407 existing COVID-19 cases and around 2.0 % of it, i.e., 685,569 deaths were reported in Brazil.

Venezuela is expected to undergo significant growth during the forecast period owing to the regular outbreak of diseases that are manageable through vaccination only and have been eradicated in the country. According to the Pan American Health Organization, more than 7,300 measles cases have been reported in Venezuela since June 2017, counting 5,500 confirmed cases and around 64 deaths as of September 2018.

The outbreak has covered all the other countries in this region, with more than 10,000 alleged cases of measles in Brazil related to the Venezuela outbreak. This reflects the growing need for hypodermic syringes and needles for vaccination over the forecast period.

Key Companies & Market Share Insights

Key players are increasingly focusing on various strategic initiatives such as mergers & acquisitions, partnerships, collaborations, and new type launches that will help them secure a strong position in the market. Key manufacturers are also focusing on investing in the expansion of their manufacturing capabilities to meet the increasing demand for the types and establish a strong revenue share in the market.

For instance, in December 2020, BD announced its plan to invest approximately USD 1.2 billion over 4 years to increase and upgrade manufacturing capacity and technology for PFS and Advanced Drug Delivery Systems (ADDS) across its six global manufacturing locations and add a new manufacturing facility in Europe. Some prominent players in the Latin America hypodermic syringes and needles market include:

• Smiths Medical

• B. Braun Medical, Inc.

• BD

• Cardinal Health

• Terumo Corporation

• Nipro Corporation

• Lifelong Meditech Private Limited

• EXELINT International, Co.

• Vitrex Medical A/S

• Retractable Technologies

Latin America Hypodermic Syringes And Needles Market Report Scope

Latin America Hypodermic Syringes and Needles Market Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the Latin America hypodermic syringes and needles market report based on type and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Needles

    • 16-18G

    • 19-21G

    • 22-25G

    • 26-29G

    • 30-32G

  • Syringes

    • 1-5ml

    • 6-10ml

    • 11-15ml

    • 16-20ml

    • 21-25ml

    • 26-30ml

    • 31-35ml

    • 36-40ml

    • 41-45ml

    • 46-50ml

  • Combination

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

    • Chile

    • Uruguay

    • Venezuela

    • Bolivia

    • Peru

    • Ecuador